Worldwide Healthcare Trust Plc (WWH) - Total Assets

Latest as of September 2025: GBX1.52 Billion GBX ≈ $184.75K USD

Based on the latest financial reports, Worldwide Healthcare Trust Plc (WWH) holds total assets worth GBX1.52 Billion GBX (≈ $184.75K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See WWH net assets for net asset value and shareholders' equity analysis.

Worldwide Healthcare Trust Plc - Total Assets Trend (2000–2025)

This chart illustrates how Worldwide Healthcare Trust Plc's total assets have evolved over time, based on quarterly financial data.

Worldwide Healthcare Trust Plc - Asset Composition Analysis

Current Asset Composition (March 2025)

Worldwide Healthcare Trust Plc's total assets of GBX1.52 Billion consist of 5.6% current assets and 94.4% non-current assets.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 5.3%
Accounts Receivable GBX5.28 Million 0.3%
Inventory GBX0.00 0.0%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX0.00 0.0%
Goodwill GBX0.00 0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how Worldwide Healthcare Trust Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Worldwide Healthcare Trust Plc (WWH) market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Worldwide Healthcare Trust Plc's current assets represent 5.6% of total assets in 2025, an increase from 0.0% in 2000.
  • Cash Position: Cash and equivalents constituted 5.3% of total assets in 2025, down from 6.7% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
  • Asset Diversification: The largest asset category is accounts receivable at 0.3% of total assets.

Worldwide Healthcare Trust Plc Competitors by Total Assets

Key competitors of Worldwide Healthcare Trust Plc based on total assets are shown below.

Company Country Total Assets
Elanor Investors Group
AU:ENN
Australia AU$673.46 Million
Flat Capital AB Series B
ST:FLAT-B
Sweden Skr6.93 Billion
Sprott Physical Gold Trust
TO:PHYS
Canada CA$14.12 Billion
Compagnie du Cambodge
PA:CBDG
France €6.94 Billion
Groep Brussel Lambert NV
BR:GBLB
Belgium €25.54 Billion
KBC Ancora
BR:KBCA
Belgium €3.63 Billion
Argo Investments Ltd
AU:ARG
Australia AU$7.91 Billion
Digitalbridge Group Inc
NYSE:DBRG
USA $3.42 Billion

Worldwide Healthcare Trust Plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.85 0.35 3.60
Quick Ratio 0.85 0.35 3.60
Cash Ratio 0.00 0.00 0.00
Working Capital GBX-11.06 Million GBX-93.91 Million GBX54.63 Million

Worldwide Healthcare Trust Plc - Advanced Valuation Insights

This section examines the relationship between Worldwide Healthcare Trust Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.89
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) -19.0%
Total Assets GBX1.78 Billion
Market Capitalization $15.54 Million USD

Valuation Analysis

Below Book Valuation: The market values Worldwide Healthcare Trust Plc's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Worldwide Healthcare Trust Plc's assets decreased by 19.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Worldwide Healthcare Trust Plc (2000–2025)

The table below shows the annual total assets of Worldwide Healthcare Trust Plc from 2000 to 2025.

Year Total Assets Change
2025-03-31 GBX1.78 Billion
≈ $216.18K
-18.99%
2024-03-31 GBX2.19 Billion
≈ $266.85K
-2.52%
2023-03-31 GBX2.25 Billion
≈ $273.75K
-7.08%
2022-03-31 GBX2.42 Billion
≈ $294.62K
-2.47%
2021-03-31 GBX2.48 Billion
≈ $302.07K
+45.78%
2020-03-31 GBX1.70 Billion
≈ $207.21K
+17.14%
2019-03-31 GBX1.45 Billion
≈ $176.89K
+20.17%
2018-03-31 GBX1.21 Billion
≈ $147.20K
0.00%
2017-03-31 GBX1.21 Billion
≈ $147.20K
+26.48%
2016-03-31 GBX956.51 Million
≈ $116.38K
-13.29%
2015-03-31 GBX1.10 Billion
≈ $134.21K
+49.31%
2014-03-31 GBX738.77 Million
≈ $89.89K
+31.27%
2013-03-31 GBX562.77 Million
≈ $68.47K
+19.37%
2012-03-31 GBX471.44 Million
≈ $57.36K
+19.59%
2011-03-31 GBX394.23 Million
≈ $47.97K
+2.14%
2010-03-31 GBX385.98 Million
≈ $46.96K
+21.94%
2009-03-31 GBX316.54 Million
≈ $38.51K
+30.65%
2008-03-31 GBX242.28 Million
≈ $29.48K
-16.92%
2007-03-31 GBX291.61 Million
≈ $35.48K
-24.26%
2006-03-31 GBX385.03 Million
≈ $46.85K
+51.72%
2005-03-31 GBX253.78 Million
≈ $30.88K
+7.96%
2004-03-31 GBX235.06 Million
≈ $28.60K
+32.23%
2003-03-31 GBX177.77 Million
≈ $21.63K
-34.93%
2002-03-31 GBX273.21 Million
≈ $33.24K
+6.79%
2001-03-31 GBX255.84 Million
≈ $31.13K
+19.52%
2000-03-31 GBX214.06 Million
≈ $26.05K
--

About Worldwide Healthcare Trust Plc

LSE:WWH UK Asset Management
Market Cap
$15.54 Million
GBX127.74 Billion GBX
Market Cap Rank
#25748 Global
#279 in UK
Share Price
GBX338.00
Change (1 day)
+1.50%
52-Week Range
GBX3.04 - GBX397.00
All Time High
GBX397.00
About

Worldwide Healthcare Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. The fund is managed by OrbiMed Capital LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the healthcare sector, with an emphasis on pharmaceutical and biotechnology companies. It primarily invests in growth stocks of large-cap … Read more